Indian Time - A Voice from the Eastern Door

Judge Invalidates Allergan's Patent With SRMT

 


Four of the company’s patents covering its blockbuster eye drug Restasis were ruled invalid on Monday, October 16, 2017, by the US District Court for the Eastern District of Texas.

According to NPR, in the order on the agreement between Allergan...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021